Skip to main content

Client News

Patronus Health GmbH Receives Angel Investment and Public Grant

16th December 2021

sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma

14th December 2021

Marinomed and Friedrich-Alexander-Universität Erlangen-Nürnberg publish new data on antiviral efficacy of iota-carrageenan against SARS-CoV-2 variants of concern

9th December 2021

Apogenix Receives EUR 20.7 Million in Public Funding for Pivotal Study and Preparation for Market Production of Asunercept for the Treatment of COVID-19

9th December 2021

RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations

6th December 2021

Atriva Therapeutics strengthens advisory board with Piet Wigerinck

2nd December 2021

Newron Pharmaceuticals S.p.A.: Change in Newron Board of Directors

1st December 2021

Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis

1st December 2021

Marinomed to present at Munich capital market conference (MKK)

1st December 2021

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results

30th November 2021